Abnormal brain oxygen homeostasis in an animal model of liver disease

JHEP Reports - Tập 4 - Trang 100509 - 2022
Anna Hadjihambi1,2,3,4, Cristina Cudalbu5,6, Katarzyna Pierzchala5,6,7, Dunja Simicic5,6, Chris Donnelly8, Christos Konstantinou3,4, Nathan Davies1, Abeba Habtesion1, Alexander V. Gourine2, Rajiv Jalan1,9, Patrick S. Hosford2,10
1UCL Institute for Liver and Digestive Health, Division of Medicine, UCL Medical School, Royal Free Hospital, Rowland Hill Street, London, UK
2Centre for Cardiovascular and Metabolic Neuroscience, Neuroscience, Physiology and Pharmacology, University College London, London, UK
3The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK
4Faculty of Life Sciences and Medicine, King’s College London, London, UK
5CIBM Center for Biomedical Imaging, Lausanne, Switzerland
6Animal Imaging and Technology, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
7Laboratory of Functional and Metabolic Imaging, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
8Institute of Sports Science and Department of Physiology, University of Lausanne, Lausanne, Switzerland
9European Foundation for the Study of Chronic Liver Failure
10William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, UK

Tài liệu tham khảo

Wijdicks, 2016, Hepatic encephalopathy, N Engl J Med, 375, 1660, 10.1056/NEJMra1600561 Hadjihambi, 2018, Hepatic encephalopathy: a critical current review, Hepatol Int, 12, 135, 10.1007/s12072-017-9812-3 Fichet, 2009, Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy, J Crit Care, 24, 364, 10.1016/j.jcrc.2009.01.008 Kornerup, 2019, Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?, Hepat Med, 11, 41, 10.2147/HMER.S144667 Shawcross, 2010, Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis, Hepatology, 51, 1062, 10.1002/hep.23367 Hadjihambi, 2014, Pharmacotherapy for hyperammonemia, Expert Opin Pharmacother, 15, 1685, 10.1517/14656566.2014.931372 Bajaj, 2011, Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement, Aliment Pharmacol Ther, 33, 739, 10.1111/j.1365-2036.2011.04590.x Cauli, 2009, Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy, Metab Brain Dis, 24, 69, 10.1007/s11011-008-9115-4 Hyder, 2006, Neuronal–glial glucose oxidation and glutamatergic-GABAergic function, J Cereb Blood Flow Metab, 26, 865, 10.1038/sj.jcbfm.9600263 Braissant, 2019, Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy, J Hepatol, 71, 505, 10.1016/j.jhep.2019.05.022 Hadjihambi, 2017, Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease, Hepatology, 65, 1306, 10.1002/hep.29031 Rao, 2001, Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia, Metab Brain Dis, 16, 67, 10.1023/A:1011666612822 Attwell, 2001, An energy budget for signaling in the grey matter of the brain, J Cereb Blood Flow Metab, 21, 1133, 10.1097/00004647-200110000-00001 Iversen, 2014, Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humans, Front Neurosci, 8, 353, 10.3389/fnins.2014.00353 Dhanda, 2018, Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy, Metab Brain Dis, 33, 209, 10.1007/s11011-017-0136-8 Heidari, 2019, Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy, Life Sci, 218, 65, 10.1016/j.lfs.2018.12.030 Willie, 2014, Integrative regulation of human brain blood flow, J Physiol, 592, 841, 10.1113/jphysiol.2013.268953 Hosford, 2019, What is the key mediator of the neurovascular coupling response?, Neurosci Biobehav Rev, 96, 174, 10.1016/j.neubiorev.2018.11.011 Lourenço, 2015, Neurovascular and neurometabolic derailment in aging and Alzheimer's disease, Front Aging Neurosci, 7, 103 Iadecola, 2017, The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease, Neuron, 96, 17, 10.1016/j.neuron.2017.07.030 Khot, 2006, Long-term neurological complications after hypoxic-ischemic encephalopathy, Semin Neurol, 26, 422, 10.1055/s-2006-948323 Dam, 2013, Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake, Hepatology, 57, 258, 10.1002/hep.25995 Iversen, 2009, Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy, Gastroenterology, 136, 863, 10.1053/j.gastro.2008.10.057 Weiss, 2018, Ammonia: this is not the end but rather the end of the beginning, J Hepatol, 68, 1110, 10.1016/j.jhep.2018.03.027 Jalan, 2007, L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy, Med Hypotheses, 69, 1064, 10.1016/j.mehy.2006.12.061 Percie du Sert, 2020, The ARRIVE guidelines 2.0: updated guidelines for reporting animal research, PLoS Biol, 18 Harry, 1999, Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat, Hepatology, 30, 1198, 10.1002/hep.510300515 Rackayova, 2016, 1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism, Metab Brain Dis, 31, 1303, 10.1007/s11011-015-9715-8 Hadjihambi, 2019, Impaired brain glymphatic flow in experimental hepatic encephalopathy, J Hepatol, 70, 40, 10.1016/j.jhep.2018.08.021 Davies, 2009, L-Ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats, Hepatology, 50, 155, 10.1002/hep.22897 Hosford, 2018, A critical role for the ATP-sensitive potassium channel subunit KIR 6.1 in the control of cerebral blood flow, J Cereb Blood Flow Metab, 39, 2089, 10.1177/0271678X18780602 Nizari, 2021, Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke, Basic Res Cardiol, 116, 32, 10.1007/s00395-021-00873-9 Haase, 2005, Influences of caffeine, acetazolamide and cognitive stimulation on cerebral blood flow velocities, Prog Neuropsychopharmacol Biol Psychiatry, 29, 549, 10.1016/j.pnpbp.2005.01.006 Vorstrup, 1984, Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen, J Clin Invest, 74, 1634, 10.1172/JCI111579 Theparambil, 2020, Astrocytes regulate brain extracellular pH via a neuronal activity-dependent bicarbonate shuttle, Nat Commun, 11, 5073, 10.1038/s41467-020-18756-3 Estrela, 2016, Differential sympathetic vasomotor activation induced by liver cirrhosis in rats, PLoS One, 11, 10.1371/journal.pone.0152512 Leithner, 2014, The oxygen paradox of neurovascular coupling, J Cereb Blood Flow Metab, 34, 19, 10.1038/jcbfm.2013.181 Balasubramaniyan, 2012, Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats, Am J Physiol Gastrointest Liver Physiol, 302, G145, 10.1152/ajpgi.00097.2011 Hoiland, 2019, Regulation of the cerebral circulation by arterial carbon dioxide, Compr Physiol, 9, 1101, 10.1002/cphy.c180021 Hein, 2006, Dilation of retinal arterioles in response to lactate: role of nitric oxide, guanylyl cyclase, and ATP-sensitive potassium channels, Invest Ophthalmol Vis Sci, 47, 693, 10.1167/iovs.05-1224 Gordon, 2008, Brain metabolism dictates the polarity of astrocyte control over arterioles, Nature, 456, 745, 10.1038/nature07525 Simicic, 2019, 33 in vivo longitudinal 1H MRS study of hippocampal, cerebral and striatal metabolic changes in the adult brain using an animal model of chronic hepatic encephalopathy, Am J Gastroenterol, 114, 10.14309/01.ajg.0000582108.29364.13 Mosso, 2022, PET CMRglc mapping and 1H MRS show altered glucose uptake and neurometabolic profiles in BDL rats, Anal Biochem, 647, 10.1016/j.ab.2022.114606 Watts, 2018, Brain energy and oxygen metabolism: emerging role in normal function and disease, Front Mol Neurosci, 11, 216, 10.3389/fnmol.2018.00216 Silverman, 2001, Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome, JAMA, 286, 2120, 10.1001/jama.286.17.2120 Zhou, 2008, Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance, Ann N Y Acad Sci, 1147, 93, 10.1196/annals.1427.023 Hadengue, 1998, Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome, J Hepatol, 29, 565, 10.1016/S0168-8278(98)80151-7 Ginès, 2009, Renal failure in cirrhosis, N Engl J Med, 361, 1279, 10.1056/NEJMra0809139 Hosford, 2019, Electrochemical carbon fiber-based technique for simultaneous recordings of brain tissue PO2, pH, and extracellular field potentials, Biosens Bioelectron X, 3 Clément, 2021, Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: implications of ammonia, J Neurochem, 157, 561, 10.1111/jnc.15290 Gibson, 1981, Brain dysfunction in mild to moderate hypoxia, Am J Med, 70, 1247, 10.1016/0002-9343(81)90834-2 Angelova, 2015, Functional oxygen sensitivity of astrocytes, J Neurosci, 35, 10460, 10.1523/JNEUROSCI.0045-15.2015 Banasiak, 1998, Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death, Brain Res, 797, 295, 10.1016/S0006-8993(98)00286-8